Nothing Special   »   [go: up one dir, main page]

ATE114472T1 - System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe. - Google Patents

System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.

Info

Publication number
ATE114472T1
ATE114472T1 AT90115881T AT90115881T ATE114472T1 AT E114472 T1 ATE114472 T1 AT E114472T1 AT 90115881 T AT90115881 T AT 90115881T AT 90115881 T AT90115881 T AT 90115881T AT E114472 T1 ATE114472 T1 AT E114472T1
Authority
AT
Austria
Prior art keywords
pulsed
delivery system
once daily
minocycline
minocycline delivery
Prior art date
Application number
AT90115881T
Other languages
English (en)
Inventor
Nitin Vadilal Sheth
Joseph James Valorose Jr
Keith Anthony Ellway
Madurai Gurusamy Ganesan
Kieran George Mooney
Jerry Bain Johnson
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE114472T1 publication Critical patent/ATE114472T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT90115881T 1989-09-21 1990-08-20 System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe. ATE114472T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41070889A 1989-09-21 1989-09-21

Publications (1)

Publication Number Publication Date
ATE114472T1 true ATE114472T1 (de) 1994-12-15

Family

ID=23625892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90115881T ATE114472T1 (de) 1989-09-21 1990-08-20 System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.

Country Status (26)

Country Link
US (2) US5300304A (de)
EP (1) EP0418565B1 (de)
JP (1) JP3140764B2 (de)
KR (1) KR100187950B1 (de)
CN (1) CN1035039C (de)
AR (1) AR244547A1 (de)
AT (1) ATE114472T1 (de)
AU (1) AU624998B2 (de)
CA (1) CA2025703C (de)
CZ (1) CZ283048B6 (de)
DD (1) DD297558A5 (de)
DE (1) DE69014513T2 (de)
DK (1) DK0418565T3 (de)
ES (1) ES2064564T3 (de)
FI (1) FI96170C (de)
HK (1) HK1000315A1 (de)
HU (1) HU221804B1 (de)
IE (1) IE66389B1 (de)
IL (1) IL95423A (de)
NO (1) NO177038C (de)
NZ (1) NZ235319A (de)
PH (1) PH30777A (de)
PL (1) PL164770B1 (de)
PT (1) PT95353B (de)
SK (1) SK279358B6 (de)
ZA (1) ZA907546B (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE114472T1 (de) * 1989-09-21 1994-12-15 American Cyanamid Co System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
TW212139B (de) * 1991-04-15 1993-09-01 Yamanouchi Pharma Co Ltd
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
AU742231B2 (en) * 1994-03-23 2001-12-20 Ortho-Mcneil Pharmaceutical, Inc. Multilayered controlled release pharmaceutical dosage form
IL109539A0 (en) * 1994-05-03 1994-08-26 Yissum Res Dev Co Substained-release pharmaceutical system for the delivery of antioxidants
DE19715594A1 (de) 1997-04-15 1998-10-22 Bayer Ag Analgetika-Kombination
US6120803A (en) * 1997-08-11 2000-09-19 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
JP2002541093A (ja) * 1999-04-06 2002-12-03 ファーマクエスト・リミテッド d−threo−メチルフェニデートおよび第2のCNS刺激薬のパルス性送達のための薬学的投薬形態
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US6251432B1 (en) * 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same
US7220430B2 (en) * 2000-01-27 2007-05-22 Tanabe Seiyaku Co., Ltd. Sustained-release preparation and process for producing the same
US6730320B2 (en) * 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
IT1318625B1 (it) 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
AU2002256092C1 (en) * 2001-04-05 2009-10-15 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
US7211267B2 (en) * 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
JP2003238393A (ja) * 2002-02-15 2003-08-27 Otsuka Pharmaceut Co Ltd 施錠性が改善された錠剤及びその製造方法
AUPS167602A0 (en) * 2002-04-12 2002-05-16 F.H. Faulding & Co. Limited An improved modified release preparation
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US20040114368A1 (en) * 2002-12-13 2004-06-17 Shyu Shing Jy Light device having rotatable or movable view
CA2894736C (en) 2003-04-07 2019-07-16 Supernus Pharmaceuticals, Inc. Once daily formulations of tetracyclines
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004258944B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1648415A4 (de) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
WO2005009416A1 (en) * 2003-07-24 2005-02-03 Ranbaxy Laboratories Limited Modified release compositions for minocycline
EP1653925A1 (de) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robustes pellet
WO2005016278A2 (en) 2003-08-12 2005-02-24 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CN1332937C (zh) * 2003-12-31 2007-08-22 赤峰东陵药业有限责任公司 新四环霉素类衍生物
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
US8715727B2 (en) 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US20060078621A1 (en) * 2004-10-13 2006-04-13 Wedinger Robert S Method of providing customized drug delivery systems
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20100215744A1 (en) * 2008-08-06 2010-08-26 Medicis Pharmaceutical Corporation Hydroxypropyl Substitution Used to Regulate Dissolution of a Chemical
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
CN101247790A (zh) * 2005-08-26 2008-08-20 Bpsi控股公司 含有控释羟丙甲纤维素基质的药物组合物
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
EP2298324A1 (de) * 2006-01-24 2011-03-23 Paratek Pharmaceuticals, Inc. Verfahren zur Verbesserung der oralen Bioverfügbarkeit von Tetracyclinen
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CN100512689C (zh) * 2006-09-28 2009-07-15 江南大学 一种用于降低卷烟烟气中焦油及自由基的添加剂及其添加方法
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
WO2008121107A1 (en) * 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
WO2016079590A1 (en) 2014-11-19 2016-05-26 Dr. Reddy's Laboratories Ltd. Modified release doxycycline composition
WO2016162754A1 (en) * 2015-04-07 2016-10-13 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline
SG11201807999XA (en) * 2016-03-29 2018-10-30 Ptt Global Chemical Public Co Ltd Coalescing agent derived from succinate ester
GB2551980A (en) * 2016-06-30 2018-01-10 Commw Scient Ind Res Org Method and system for low level metal analysis of mineral samples

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB310814A (en) * 1927-08-05 1929-05-31 Bates Valve Bag Corp Method of and apparatus for filling bags
GB327295A (en) * 1929-04-12 1930-04-03 Edward Lloyd Pease Improvements in or relating to tanks having external cooling elements, applicable tooil tanks for electrical transformers
NL270408A (de) * 1960-10-20
US3148212A (en) * 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
USRE26253E (en) * 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3356571A (en) * 1964-11-25 1967-12-05 American Cyanamid Co Potentiation of tetracycline by polyacrylic acid or hydrolyzed polyacrylonitrile
CH434571A (de) * 1966-07-05 1967-04-30 Chemical And Pharmaceutical Pa Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung
US3865935A (en) * 1972-08-10 1975-02-11 Abbott Lab Tableting of erythromycin base
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
FR2447192A1 (fr) * 1979-01-25 1980-08-22 Adria Lab Inc Forme galenique a liberation prolongee d'indoprofene
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
EP0327295A3 (de) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracyclin-Dosisform
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
ATE114472T1 (de) * 1989-09-21 1994-12-15 American Cyanamid Co System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.

Also Published As

Publication number Publication date
FI96170C (fi) 1996-05-27
HK1000315A1 (en) 1998-02-27
EP0418565A3 (en) 1991-09-25
PL286971A1 (en) 1992-01-27
US5300304A (en) 1994-04-05
DE69014513T2 (de) 1995-05-24
NZ235319A (en) 1993-03-26
EP0418565A2 (de) 1991-03-27
DK0418565T3 (da) 1995-01-23
HU906006D0 (en) 1991-03-28
NO177038C (no) 1995-07-12
DD297558A5 (de) 1992-01-16
NO177038B (no) 1995-04-03
IE66389B1 (en) 1995-12-27
HUT59314A (en) 1992-05-28
ZA907546B (en) 1991-07-31
IL95423A0 (en) 1991-06-30
CZ283048B6 (cs) 1997-12-17
DE69014513D1 (de) 1995-01-12
ES2064564T3 (es) 1995-02-01
AU6303190A (en) 1991-03-28
FI904634A0 (fi) 1990-09-20
CN1050320A (zh) 1991-04-03
CN1035039C (zh) 1997-06-04
JPH03112930A (ja) 1991-05-14
CZ455990A3 (en) 1997-08-13
KR100187950B1 (ko) 1999-06-01
PT95353A (pt) 1991-08-14
FI96170B (fi) 1996-02-15
NO904099L (no) 1991-03-22
JP3140764B2 (ja) 2001-03-05
CA2025703C (en) 2002-08-27
PL164770B1 (pl) 1994-10-31
NO904099D0 (no) 1990-09-20
HU221804B1 (hu) 2003-01-28
PH30777A (en) 1997-10-17
PT95353B (pt) 1998-05-29
AR244547A1 (es) 1993-11-30
AU624998B2 (en) 1992-06-25
US5413777A (en) 1995-05-09
CA2025703A1 (en) 1991-03-22
KR910005875A (ko) 1991-04-27
SK455990A3 (en) 1998-10-07
SK279358B6 (sk) 1998-10-07
IE903398A1 (en) 1991-04-10
IL95423A (en) 1994-11-11
EP0418565B1 (de) 1994-11-30

Similar Documents

Publication Publication Date Title
ATE114472T1 (de) System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
LT2185B (lt) 5'-dezoksi-5-fluorcitidino dariniu gavimo budas
HU9302666D0 (en) Biological insecticide
DE69203249D1 (de) Vorrichtung zur Blutreinigung.
OA09194A (en) "Insecticidal treatment and compositions therefor".
KR950700707A (ko) 치과용 치료시스템
AU5216690A (en) Periodontal disease treatment system
DE69202707D1 (de) Alkylmethylsiloxane zur Hautpflege.
DE58906881D1 (de) Gerät zur Zahnbehandlung.
IT1227849B (it) Composizione per l'igiene orale.
IT9047924A0 (it) Composizione per l'igiene orale.
DE69006899D1 (de) Mittel zur oralen Spülung.
FR2684540B1 (fr) Implant dentaire.
DE69021536D1 (de) Zahnimplantatsystem.
FR2720558B1 (fr) Système d'alimentation sécurisé.
IT1244668B (it) Impianto dentale endosseo.
GB2247602B (en) Horseshoe
DE59006623D1 (de) Vorrichtung zur Hubbegrenzung.
IT9048026A0 (it) Preparato farmaceutico e/o cosmetico.
DE69002821D1 (de) Zusammensetzung zur haarbehandlung.
KR940007408U (ko) 메세지 전달 카드
GB2235637B (en) Horseshoe sprinlker
ES1023915Y (es) Implante dental.
ES1021400Y (es) Conjunto de higiene dental desechable.
ES1019967Y (es) Compresa higienica perfeccionada.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee